Increased glycemic variability and decrease of the postprandial glucose contribution to HbA1c in obese subjects across the glycemic continuum from normal glycemia to first time diagnosed diabetes

Metabolism: Clinical and Experimental

Volumn 63, Issue 12, 2014, Pages 1553-1561

  Fysekidis, Marinos ^a   Cosson, Emmanuel ^a   Banu, Isabela ^a   Duteil, Régine ^a   Cyrille, Chantal ^a   Valensi, Paul ^a  

^a UNIVERSITÉ PARIS 13   (France)

Author keywords

Contribution to Hb1Ac; Obesity; Prediabetes

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BLOOD GLUCOSE MONITORING; CONTROLLED STUDY; DIABETES MELLITUS; DIET RESTRICTION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; MAJOR CLINICAL STUDY; MALE; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PHYSICAL ACTIVITY; PRIORITY JOURNAL; ADOLESCENT; BLOOD; COHORT ANALYSIS; GLUCOSE TOLERANCE TEST; METABOLISM; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; BLOOD GLUCOSE; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERGLYCEMIA; MALE; MIDDLE AGED; OBESITY; OVERWEIGHT; YOUNG ADULT;

EID: 84922191929     PISSN: 00260495     EISSN: 15328600     Source Type: Journal    
DOI: 10.1016/j.metabol.2014.09.006     Document Type: Article

References (45)

1. International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes Diabetes Care 32 2009 1327 1334
2. I.M. Stratton, A.I. Adler, and H.A. Neil Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study BMJ 321 2000 405 412
3. R.R. Little, C.L. Rohlfing, and H.M. Wiedmeyer The national glycohemoglobin standardization program: a five-year progress report Clin Chem 47 2001 1985 1992
4. R.L. Ollerton, R. Playle, and K. Ahmed Day-to-day variability of fasting plasma glucose in newly diagnosed type 2 diabetic subjects Diabetes Care 22 1999 394 398
5. Standards of medical care in diabetes - 2013 Diabetes Care 36 Suppl. 1 2013 S11 S66
6. L. Monnier, H. Lapinski, and C. Colette Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA(1c) Diabetes Care 26 2003 881 885
7. L. Monnier, C. Colette, and D.R. Owens Glycemic variability: the third component of the dysglycemia in diabetes. Is it important? How to measure it? J Diabetes Sci Technol 2 2008 1094 1100
8. Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. The DECODE study group. European Diabetes Epidemiology Group. Diabetes Epidemiology: Collaborative analysis Of Diagnostic criteria in Europe Lancet 354 1999 617 621
9. M. Brownlee, and I.B. Hirsch Glycemic variability: a hemoglobin A1c-independent risk factor for diabetic complications JAMA 295 2006 1707 1708
10. I.B. Hirsch, and M. Brownlee Should minimal blood glucose variability become the gold standard of glycemic control? J Diabetes Complications 19 2005 178 181
11. L. Monnier, E. Mas, C. Ginet, and F. Michel Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes JAMA 295 2006 1681 1687
12. A. Ceriello, A. Novials, and E. Ortega Evidence that hyperglycemia after recovery from hypoglycemia worsens endothelial function and increases oxidative stress and inflammation in healthy control subjects and subjects with type 1 diabetes Diabetes 61 2012 2993 2997
13. U.K. Prospective Diabetes Study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease. U.K. Prospective Diabetes Study Group Diabetes 44 1995 1249 1258
14. L. Monnier, C. Colette, G.J. Dunseath, and D.R. Owens The loss of postprandial glycemic control precedes stepwise deterioration of fasting with worsening diabetes Diabetes Care 30 2007 263 269
15. R.E. Pratley, and C. Weyer The role of impaired early insulin secretion in the pathogenesis of type II diabetes mellitus Diabetologia 44 2001 929 945
16. M. Kanat, L. Norton, and D. Winnier Impaired early- but not late-phase insulin secretion in subjects with impaired fasting glucose Acta Diabetol 48 2011 209 217
17. G.M. Reaven, R.J. Brand, and Y.D. Chen Insulin resistance and insulin secretion are determinants of oral glucose tolerance in normal individuals Diabetes 42 1993 1324 1332
18. B. Paulweber, P. Valensi, and J. Lindstrom A European evidence-based guideline for the prevention of type 2 diabetes Horm Metab Res 42 Suppl. 1 2010 S3 S36
19. Diagnosis and classification of diabetes mellitus Diabetes Care 34 Suppl. 1 2011 S62 S69
20. P. Valensi, B. Lormeau, and M. Dabbech Glucose-induced thermogenesis, inhibition of lipid oxidation rate and autonomic dysfunction in non-diabetic obese women Int J Obes Relat Metab Disord 22 1998 494 499
21. L. Monnier, C. Colette, H. Lapinski, and H. Boniface Self-monitoring of blood glucose in diabetic patients: from the least common denominator to the greatest common multiple Diabetes Metab 30 2004 113 119
22. N.R. Hill, N.S. Oliver, P. Choudhary, and J.C. Levy Normal reference range for mean tissue glucose and glycemic variability derived from continuous glucose monitoring for subjects without diabetes in different ethnic groups Diabetes Technol Ther 13 2011 921 928
23. D. Rodbard Interpretation of continuous glucose monitoring data: glycemic variability and quality of glycemic control Diabetes Technol Ther 11 Suppl. 1 2009 S55 S67
24. D.R. Matthews, J.P. Hosker, and A.S. Rudenski Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man Diabetologia 28 1985 412 419
25. R.A. DeFronzo, and M. Matsuda Reduced time points to calculate the composite index Diabetes Care 33 7 2010 e93
26. E. Cosson, S. Chiheb, and E. Hamo-Tchatchouang Use of clinical scores to detect dysglycaemia in overweight or obese women Diabetes Metab 38 2012 217 224
27. E. Cosson, M.T. Nguyen, and E. Hamo-Tchatchouang What would be the outcome if the American Diabetes Association recommendations of 2010 had been followed in our practice in 1998-2006 Diabet Med 28 5 2011 567 574
28. P. An, I. Miljkovic, B. Thyagarajan, and A.T. Kraja Genome-wide association study identifies common loci influencing circulating glycated hemoglobin (HbA1c) levels in non-diabetic subjects: the Long Life Family Study (LLFS) Metabolism 63 4 2014 461 468
29. S. Ebenibo, C. Edeoga, J. Wan, and S. Dagogo-Jack Glucoregulatory function among African Americans and European Americans with normal or pre-diabetic hemoglobin A1c levels Metabolism 63 6 2014 767 772
30. D.M. Nathan, J. Kuenen, and R. Fau - Borg Translating the A1C assay into estimated average glucose values Diabetes Care 31 8 2008 1473 1478
31. G. Bock, C. Dalla Man, and M. Campioni Pathogenesis of pre-diabetes: mechanisms of fasting and postprandial hyperglycemia in people with impaired fasting glucose and/or impaired glucose tolerance Diabetes 55 2006 3536 3549
32. R.P. Donahue, R.D. Abbott, D.M. Reed, and K. Yano Postchallenge glucose concentration and coronary heart disease in men of Japanese ancestry. Honolulu Heart Program Diabetes 36 1987 689 692
33. F. de Vegt, J.M. Dekker, and H.G. Ruhe Hyperglycaemia is associated with all-cause and cardiovascular mortality in the Hoorn population: the Hoorn Study Diabetologia 42 1999 926 931
34. B. Balkau, M. Shipley, and R.J. Jarrett High blood glucose concentration is a risk factor for mortality in middle-aged nondiabetic men. 20-year follow-up in the Whitehall Study, the Paris Prospective Study, and the Helsinki Policemen Study Diabetes Care 21 1998 360 367
35. J.B. Meigs, D.M. Nathan, R.B. D'Agostino Sr., and P.W. Wilson Fasting and postchallenge glycemia and cardiovascular disease risk: the Framingham Offspring Study Diabetes Care 25 2002 1845 1850
36. J.L. Chiasson, R.G. Josse, and R. Gomis Acarbose for the prevention of type 2 diabetes, hypertension and cardiovascular disease in subjects with impaired glucose tolerance: facts and interpretations concerning the critical analysis of the STOP-NIDDM Trial data Diabetologia 47 2004 969 975
37. C.M. Ma, F.Z. Yin, R. Wang, and C.M. Qin Glycemic variability in abdominally obese men with normal glucose tolerance as assessed by continuous glucose monitoring system Obesity (Silver Spring) 19 2011 1616 1622
38. C.K. Kramer, Choi H. Fau, and B. Zinman Glycemic variability in patients with early type 2 diabetes: the impact of improvement in beta-cell function Diabetes Care 37 4 2014 1116 1123
39. A. Ceriello, C. Taboga, and L. Tonutti Evidence for an independent and cumulative effect of postprandial hypertriglyceridemia and hyperglycemia on endothelial dysfunction and oxidative stress generation: effects of short- and long-term simvastatin treatment Circulation 106 2002 1211 1218
40. E. Selvin, M.W. Steffes, and H. Zhu Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults N Engl J Med 362 2010 800 811
41. N. Papanas, and D. Ziegler Polyneuropathy in impaired glucose tolerance: is postprandial hyperglycemia the main culprit? A mini-review Gerontology 59 2013 193 198
42. J.R. Singleton, A.G. Smith, J.W. Russell, and E.L. Feldman Microvascular complications of impaired glucose tolerance Diabetes 52 2003 2867 2873
43. E.S. Kilpatrick, A.S. Rigby, and S.L. Atkin The effect of glucose variability on the risk of microvascular complications in type 1 diabetes Diabetes Care 29 2006 1486 1490
44. S.E. Siegelaar, L. Kerr, S.J. Jacober, and J.H. Devries A decrease in glucose variability does not reduce cardiovascular event rates in type 2 diabetic patients after acute myocardial infarction: a reanalysis of the HEART2D study Diabetes Care 34 2011 855 857
45. P.A. Baghurst, D. Rodbard, and F.J. Cameron The minimum frequency of glucose measurements from which glycemic variation can be consistently assessed J Diabetes Sci Technol 4 2010 1382 1385